It has been reported that in melanoma cells with mutated RAS, activation of the MAPK signalling pathway occurs preferentially through CRAF instead of BRAF (Dumaz et al. 2006; Bradish and Cheng 2014). The gene discussed is RAF1; the disease is melanoma.